Quanex Building Products (NX) 10-Q 3 Sep 21 2021 Q3 Quarterly report Financial data

Cover page

Cover page - shares	9 Months Ended
	Jul. 31, 2021	Aug. 31, 2021
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jul. 31, 2021
Document Transition Report	false
Entity File Number	1-33913
Entity Registrant Name	QUANEX BUILDING PRODUCTS CORPORATION
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	26-1561397
Entity Address, Address Line One	1800 West Loop South
Entity Address, Address Line Two	Suite 1500
Entity Address, City or Town	Houston
Entity Address, State or Province	TX
Entity Address, Postal Zip Code	77027
City Area Code	713
Local Phone Number	961-4600
Title of 12(b) Security	Common Stock, par value $0.01 per share
Trading Symbol	NX
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Central Index Key	0001423221
Current Fiscal Year End Date	--10-31
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q3
Amendment Flag	false
Entity Common Stock, Shares Outstanding		33,521,788

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Jul. 31, 2021	Oct. 31, 2020
Current assets:
Cash and cash equivalents	$ 43,663	$ 51,621
Accounts receivable, net of allowance for credit losses of $352 and $161	98,286	88,287
Inventories, net	93,493	61,181
Prepaid and other current assets	9,133	6,217
Total current assets	244,575	207,306
Property, plant and equipment, net of accumulated depreciation of $333,788 and $340,144	176,032	184,104
Operating lease right-of-use assets	54,811	51,824
Goodwill	150,487	146,154
Intangible assets, net	86,026	93,068
Other assets	7,261	9,129
Total assets	719,192	691,585
Current liabilities:
Accounts payable	79,167	77,335
Accrued liabilities	52,751	38,289
Income taxes payable	1,327	6,465
Current maturities of long-term debt	839	692
Current operating lease liabilities	8,270	7,459
Total current liabilities	142,354	130,240
Long-term debt	72,439	116,728
Noncurrent operating lease liabilities	47,371	44,873
Deferred pension and postretirement benefits	10,765	10,923
Deferred income taxes	25,252	19,116
Other liabilities	15,622	13,946
Total liabilities	313,803	335,826
Commitments and contingencies
Stockholders’ equity:
Preferred stock, no par value, shares authorized 1,000,000; issued and outstanding - none	0	0
Common stock, $0.01 par value, shares authorized 125,000,000; issued 37,273,510 and 37,296,166, respectively; outstanding 33,521,788 and 32,804,737, respectively	373	373
Additional paid-in-capital	253,662	253,458
Retained earnings	241,582	213,517
Accumulated other comprehensive loss	(22,968)	(33,024)
Less: Treasury stock at cost, 3,751,722 and 4,491,429 shares, respectively	(67,260)	(78,565)
Total stockholders’ equity	405,389	355,759
Total liabilities and stockholders' equity	$ 719,192	$ 691,585

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($) $ in Thousands	Jul. 31, 2021	Oct. 31, 2020
Statement of Financial Position [Abstract]
Allowance for doubtful accounts	$ 352	$ 161
Accumulated depreciation of property, plant and equipment	$ 333,788	$ 340,144
Preferred stock, no par value	$ 0	$ 0
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value (in usd per share)	$ 0.01	$ 0.01
Common stock, shares authorized	125,000,000	125,000,000
Common stock, shares issued	37,273,510	37,296,166
Common stock, shares outstanding	33,521,788	32,804,737
Treasury stock, shares	3,751,722	4,491,429

Condensed Consolidated Statemen

Condensed Consolidated Statements of Income (Loss) (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 31, 2021	Jul. 31, 2020	Jul. 31, 2021	Jul. 31, 2020
Income Statement [Abstract]
Net sales	$ 279,877	$ 212,096	$ 780,381	$ 596,168
Cost and expenses:
Cost of sales (excluding depreciation and amortization)	219,866	162,427	604,723	469,586
Selling, general and administrative	27,766	21,973	88,299	62,818
Restructuring charges	0	73	39	477
Depreciation and amortization	10,683	11,060	32,543	35,851
Operating income	21,562	16,563	54,777	27,436
Non-operating (expense) income:
Interest expense	(597)	(1,165)	(1,988)	(4,310)
Other, net	188	(220)	645	116
Income before income taxes	21,153	15,178	53,434	23,242
Income tax expense	(7,474)	(4,345)	(17,352)	(6,898)
Net income	$ 13,679	$ 10,833	$ 36,082	$ 16,344
Basic earnings per common share	$ 0.41	$ 0.33	$ 1.09	$ 0.50
Diluted earnings per common share	$ 0.41	$ 0.33	$ 1.08	$ 0.50
Weighted-average common shares outstanding:
Basic (in shares)	33,359	32,610	33,194	32,716
Diluted (in shares)	33,650	32,739	33,518	32,845
Cash dividends per share (in usd per share)	$ 0.08	$ 0.08	$ 0.24	$ 0.24

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 31, 2021	Jul. 31, 2020	Jul. 31, 2021	Jul. 31, 2020
Statement of Comprehensive Income [Abstract]
Net income	$ 13,679	$ 10,833	$ 36,082	$ 16,344
Other comprehensive income:
Foreign currency translation gain	424	7,344	10,056	3,088
Change in pension from net unamortized gain adjustment (pretax)	0	0	0	2,519
Change in pension from net unamortized gain adjustment tax expense	0	0	0	(609)
Other comprehensive income	424	7,344	10,056	4,998
Comprehensive income	$ 14,103	$ 18,177	$ 46,138	$ 21,342

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flow (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Jul. 31, 2021	Jul. 31, 2020
Operating activities:
Net income	$ 36,082	$ 16,344
Adjustments to reconcile net income to cash provided by operating activities:
Depreciation and amortization	32,543	35,851
Stock-based compensation	1,470	513
Deferred income tax	5,429	438
Other, net	5,485	762
Changes in assets and liabilities:
Increase in accounts receivable	(8,277)	(1,852)
(Increase) decrease in inventory	(32,113)	3,553
(Increase) decrease in other current assets	(2,768)	1,218
Increase (decrease) in accounts payable	1,600	(1,878)
Increase (decrease) in accrued liabilities	12,521	(7,611)
(Decrease) increase in income taxes payable	(5,158)	107
(Decrease) increase in deferred pension and postretirement benefits	(158)	573
Increase (decrease) in other long-term liabilities	962	(181)
Other, net	(183)	(276)
Cash provided by operating activities	47,435	47,561
Investing activities:
Capital expenditures	(16,006)	(20,673)
Proceeds from disposition of capital assets	3,138	131
Cash used for investing activities	(12,868)	(20,542)
Financing activities:
Borrowings under credit facility	0	114,500
Repayments of credit facility borrowings	(45,000)	(119,000)
Repayments of other long-term debt	(502)	(791)
Common stock dividends paid	(8,017)	(7,910)
Issuance of common stock	16,272	2,954
Payroll tax paid to settle shares forfeited upon vesting of stock	(492)	(454)
Purchase of treasury stock	(5,741)	(6,693)
Cash used for financing activities	(43,480)	(17,394)
Effect of exchange rate changes on cash and cash equivalents	955	580
(Decrease) increase in cash and cash equivalents	(7,958)	10,205
Cash and cash equivalents at beginning of period	51,621	30,868
Cash and cash equivalents at end of period	$ 43,663	$ 41,073

Condensed Consolidated Statem_4

Condensed Consolidated Statement of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Income (Loss)	Treasury Stock
Balance at beginning of period at Oct. 31, 2019	$ 330,187	$ 374	$ 254,673	$ 185,703	$ (33,817)	$ (76,746)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	10			10
Foreign currency translation adjustment	2,743				2,743
Common dividends ($0.08 per share)	(2,659)			(2,659)
Purchase of treasury stock	(4,639)					(4,639)
Change in pension from net unamortized loss (net of tax expense of $609)	1,910				1,910
Stock-based compensation activity:
Expense related to stock-based compensation	(239)		(239)
Stock options exercised	3,075		92	(159)		3,142
Restricted stock awards granted	0		(1,082)	94		988
Performance restricted stock units vested			(495)			495
Other	(455)	(1)	(454)
Balance at end of period at Jan. 31, 2020	$ 329,933	373	252,495	182,989	(29,164)	(76,760)
Stock-based compensation activity:
Cash dividends per share (in usd per share)	$ 0.08
Balance at beginning of period at Oct. 31, 2019	$ 330,187	374	254,673	185,703	(33,817)	(76,746)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	16,344
Balance at end of period at Jul. 31, 2020	$ 339,938	373	253,144	193,989	(28,819)	(78,749)
Stock-based compensation activity:
Cash dividends per share (in usd per share)	$ 0.24
Balance at beginning of period at Jan. 31, 2020	$ 329,933	373	252,495	182,989	(29,164)	(76,760)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	5,501			5,501
Foreign currency translation adjustment	(6,999)				(6,999)
Common dividends ($0.08 per share)	(2,628)			(2,628)
Purchase of treasury stock	(2,054)					(2,054)
Stock-based compensation activity:
Expense related to stock-based compensation	325		325
Stock options exercised	(121)		(38)	(83)
Restricted stock awards granted			(65)			65
Balance at end of period at Apr. 30, 2020	$ 323,957	373	252,717	185,779	(36,163)	(78,749)
Stock-based compensation activity:
Cash dividends per share (in usd per share)	$ 0.08
Net income	$ 10,833			10,833
Foreign currency translation adjustment	7,344				7,344
Common dividends ($0.08 per share)	(2,623)			(2,623)
Expense related to stock-based compensation	427		427
Balance at end of period at Jul. 31, 2020	$ 339,938	373	253,144	193,989	(28,819)	(78,749)
Stock-based compensation activity:
Cash dividends per share (in usd per share)	$ 0.08
Balance at beginning of period at Oct. 31, 2020	$ 355,759	373	253,458	213,517	(33,024)	(78,565)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	7,852			7,852
Foreign currency translation adjustment	8,600				8,600
Common dividends ($0.08 per share)	(2,637)			(2,637)
Purchase of treasury stock	(1,927)					(1,927)
Stock-based compensation activity:
Expense related to stock-based compensation	523		523
Stock options exercised	10,030		635			9,395
Restricted stock awards granted	0		(1,282)			1,282
Performance restricted stock units vested			(565)			565
Other	(492)		(492)
Balance at end of period at Jan. 31, 2021	$ 377,708	373	252,277	218,732	(24,424)	(69,250)
Stock-based compensation activity:
Cash dividends per share (in usd per share)	$ 0.08
Balance at beginning of period at Oct. 31, 2020	$ 355,759	373	253,458	213,517	(33,024)	(78,565)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	36,082
Balance at end of period at Jul. 31, 2021	$ 405,389	373	253,662	241,582	(22,968)	(67,260)
Stock-based compensation activity:
Cash dividends per share (in usd per share)	$ 0.24
Balance at beginning of period at Jan. 31, 2021	$ 377,708	373	252,277	218,732	(24,424)	(69,250)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	14,551			14,551
Foreign currency translation adjustment	1,032				1,032
Common dividends ($0.08 per share)	(2,693)			(2,693)
Purchase of treasury stock	(2,041)					(2,041)
Stock-based compensation activity:
Expense related to stock-based compensation	447		447
Stock options exercised	6,093		423			5,670
Balance at end of period at Apr. 30, 2021	$ 395,097	373	253,147	230,590	(23,392)	(65,621)
Stock-based compensation activity:
Cash dividends per share (in usd per share)	$ 0.08
Net income	$ 13,679			13,679
Foreign currency translation adjustment	424				424
Common dividends ($0.08 per share)	(2,687)			(2,687)
Purchase of treasury stock	(1,773)					(1,773)
Expense related to stock-based compensation	500		500
Stock options exercised	149		15			134
Balance at end of period at Jul. 31, 2021	$ 405,389	$ 373	$ 253,662	$ 241,582	$ (22,968)	$ (67,260)
Stock-based compensation activity:
Cash dividends per share (in usd per share)	$ 0.08

Condensed Consolidated Statem_5

Condensed Consolidated Statement of Stockholders' Equity (Unaudited) (Parenthetical)	3 Months Ended
	Jan. 31, 2020USD ($)$ / shares
Statement of Stockholders' Equity [Abstract]
Cash dividends per share (in usd per share) | $ / shares	$ 0.08
Change in pension from net unamortized loss, tax | $	$ 609,000

Nature of Operations and Basis

Nature of Operations and Basis of Presentation	9 Months Ended
	Jul. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Nature of Operations and Basis of Presentation	Nature of Operations and Basis of Presentation Quanex Building Products Corporation is a component supplier to original equipment manufacturers (OEMs) in the building products industry. These components can be categorized as window and door (fenestration) components and kitchen and bath cabinet components. Examples of fenestration components include: (1) energy-efficient flexible insulating glass spacers, (2) extruded vinyl profiles, (3) window and door screens, and (4) precision-formed metal and wood products. We also manufacture cabinet doors and other components for OEMs in the kitchen and bathroom cabinet industry. In addition, we provide certain other non-fenestration components and products, which include solar panel sealants, trim moldings, vinyl decking, vinyl fencing, water retention barriers, and conservatory roof components. We have organized our business into three reportable business segments. For additional discussion of our reportable business segments, see Note 11, “Segment Information.” We use low-cost, short lead-time production processes and engineering expertise to provide our customers with specialized products for their specific window, door, and cabinet applications. We believe these capabilities provide us with unique competitive advantages. We serve a primary customer base in North America and the United Kingdom (U.K.), and also serve customers in international markets through our operating plants in the U.K. and Germany, as well as through sales and marketing efforts in other countries. Unless the context indicates otherwise, references to “Quanex”, the “Company”, “we”, “us” and “our” refer to the consolidated business operations of Quanex Building Products Corporation and its subsidiaries. The accompanying interim unaudited condensed consolidated financial statements include the accounts of Quanex Building Products Corporation. All intercompany accounts and transactions have been eliminated in consolidation. These financial statements have been prepared by us, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (SEC). Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP) have been condensed or omitted pursuant to such rules and regulations. The condensed consolidated balance sheet as of October 31, 2020 was derived from audited financial information but does not include all disclosures required by U.S. GAAP. The accompanying financial statements should be read in conjunction with the audited consolidated financial statements and the notes thereto, included in our Annual Report on Form 10-K for the fiscal year ended October 31, 2020. In our opinion, the accompanying financial statements contain all adjustments (which consist of normal recurring adjustments, except as disclosed herein) necessary to fairly present our financial position, results of operations and cash flows for the interim periods. The results of operations for the periods presented are not necessarily indicative of the results to be expected for the full year or for any future periods. In preparing financial statements, we make informed judgments and estimates that affect the reported amounts of assets and liabilities as of the date of the financial statements and affect the reported amounts of revenues and expenses during the reporting period. We review our estimates on an on-going basis, including those related to impairment of long-lived assets and goodwill, contingencies and income taxes. Changes in facts and circumstances may result in revised estimates and actual results may differ from these estimates. Revenue from Contracts with Customers Revenue recognition We recognize revenue that reflects the consideration we expect to receive for product sales upon transfer to customers. Revenue for product sales is recognized when control of the promised products is transferred to our customers, and we are entitled to consideration in exchange for such transfer. We account for a contract when a customer provides us with a firm purchase order that identifies the products to be provided, the payment terms for those products, and when collectability of the consideration due is probable. Performance obligations A performance obligation is a promise to provide the customer with a good or service. Our performance obligations include product sales, with each product included in a customer contract being recognized as a separate performance obligation. For contracts with multiple performance obligations, the standalone selling price of each product is generally readily observable. Revenue from product sales is recognized at a point in time when the product is transferred to the customer, in accordance with the shipping terms, which is generally upon shipment. We estimate a provision for sales returns and warranty allowances to account for product returns related to general returns and product nonconformance. We generally expense incremental costs of obtaining a contract when incurred because the amortization period would be less than one year. Additionally, we do not disclose the value of unsatisfied performance obligations for contracts with an original expected length of one year or less. Pricing and sales incentives Pricing is established at or prior to the time of sale with our customers and we record sales at the agreed-upon net selling price, reflective of current and prospective discounts. Shipping and handling costs We account for shipping and handling services as fulfillment services; accordingly, freight revenue is combined with the product deliverable rather than being accounted for as a distinct performance obligation within the terms of the agreement. Shipping and handling costs incurred by us for the delivery of goods to customers are considered a cost to fulfill the contract and are included in cost of sales in the accompanying condensed consolidated statements of income. Contract assets and liabilities Deferred revenue, which is not significant, is recorded when we have remaining unsatisfied performance obligations for which we have received consideration. Disaggregation of revenue We produce a wide variety of products that are used in the fenestration industry, including window spacer systems; extruded vinyl products; metal fabricated products; and astragals, thresholds and screens. In addition, we produce certain non-fenestration products, including kitchen and bath cabinet doors and components, flooring and trim moldings, solar edge tape, plastic decking, fencing, water retention barriers, conservatory roof components, and other products. The following table summarizes our product sales for the three and nine months ended July 31, 2021 and 2020 into groupings by segment which we believe depicts how the nature, amount, timing and uncertainty of our revenues and cash flows are affected by economic factors. For further details regarding our results by segment, refer to Note 11, “Segment Information”. Three Months Ended Nine Months Ended July 31, July 31, 2021 2020 2021 2020 (In thousands) North American Fenestration: United States - fenestration $ 129,291 $ 109,455 $ 369,809 $ 302,094 International - fenestration 9,581 6,696 25,756 19,284 United States - non-fenestration 5,853 4,845 17,543 13,779 International - non-fenestration 3,093 1,390 8,969 6,275 $ 147,818 $ 122,386 $ 422,077 $ 341,432 European Fenestration: International - fenestration $ 54,883 $ 31,904 $ 147,072 87,732 International - non-fenestration 16,231 6,361 34,790 16,498 $ 71,114 $ 38,265 $ 181,862 $ 104,230 North American Cabinet Components: United States - fenestration $ 3,240 $ 2,666 $ 9,711 $ 8,461 United States - non-fenestration 57,418 48,849 168,308 142,838 International - non-fenestration 1,278 410 1,473 1,335 $ 61,936 $ 51,925 $ 179,492 $ 152,634 Unallocated Corporate & Other Eliminations $ (991) $ (480) $ (3,050) $ (2,128) $ (991) $ (480) $ (3,050) $ (2,128) Net sales $ 279,877 $ 212,096 $ 780,381 $ 596,168 Allowance for Credit Losses We have established an allowance for credit losses to estimate the risk of losses, which represents an estimate of expected losses over the remaining contractual life of our receivables. The allowance is determined using two methods. The amounts calculated from each of these methods are combined to determine the total amount reserved. First, a specific reserve is established for individual accounts where information indicates the customers may have an inability to meet financial obligations. Second, a reserve is determined for all customers based on a range of percentages applied to aging categories. These percentages are based on historical collection rates, write-off experience, and forecasts of future economic conditions. Actual write-offs are charged against the allowance when collection efforts have been unsuccessful. COVID-19 Impact On March 11, 2020, the World Health Organization (WHO) declared the outbreak of COVID-19 as a global pandemic and advised aggressive containment action. The COVID-19 pandemic and its impacts are continuing to have an adverse effect on many sectors of the economy. Measures providing for business shutdowns generally exclude certain essential services commonly including critical infrastructure such as construction and the businesses that support that critical infrastructure. To date, we have not experienced significant challenges or expenses implementing crisis management plans intended for containment and prevention. The health and safety of our employees are high priority. In response to the COVID-19 pandemic, we have taken additional measures to limit possible infections at the workplace by implementing social distancing, sanitizing the workspace, and requiring employees to report any COVID-19 symptoms to ensure safety as infection surges dictate. We continue to assess and refine these measures on an ongoing basis as public health guidance and applicable laws and regulations continue to evolve.

Inventories

Inventories	9 Months Ended
	Jul. 31, 2021
Inventory Disclosure [Abstract]
Inventories	Inventories Inventories consisted of the following at July 31, 2021 and October 31, 2020 (in thousands): July 31, October 31, Raw materials $ 46,810 $ 33,298 Finished goods and work in process 45,728 32,347 Supplies and other 2,459 2,020 Total 94,997 67,665 Less: Inventory reserves 1,504 6,484 Inventories, net $ 93,493 $ 61,181

Goodwill and Intangible Assets

Goodwill and Intangible Assets	9 Months Ended
	Jul. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets	Goodwill and Intangible Assets Goodwill The change in the carrying amount of goodwill for the nine months ended July 31, 2021 was as follows (in thousands): Nine Months Ended July 31, 2021 Beginning balance as of November 1, 2020 $ 146,154 Foreign currency translation adjustment 4,333 Balance as of the end of the period $ 150,487 At our last annual test date, August 31, 2020, we evaluated the recoverability of goodwill at each of our five reporting units with goodwill balances and determined that our goodwill was not impaired. We evaluated for indicators of impairment during the three and nine months ended July 31, 2021 and determined that there were no triggering events. For a summary of the change in the carrying amount of goodwill by segment, see Note 11, “Segment Information.” Identifiable Intangible Assets Amortizable intangible assets consisted of the following as of July 31, 2021 and October 31, 2020 (in thousands): July 31, 2021 October 31, 2020 Gross Carrying Accumulated Gross Carrying Accumulated Customer relationships $ 146,850 $ 78,785 $ 154,004 $ 80,441 Trademarks and trade names 56,635 39,164 55,745 37,314 Patents and other technology 22,546 22,056 22,386 21,312 Total $ 226,031 $ 140,005 $ 232,135 $ 139,067 We had aggregate amortization expense related to intangible assets for the three and nine months ended July 31, 2021 of $3.0 million and $9.7 million, respectively, and $3.4 million and $10.8 million, respectively, for the comparable prior year periods. We retired fully amortized identifiable assets of $9.9 million related to customer relationships during the nine months ended July 31, 2021. Estimated remaining amortization expense, based on current intangible balances, for each of the fiscal years ending October 31, is as follows (in thousands): Estimated 2021 (remaining three months) $ 3,057 2022 12,181 2023 11,422 2024 10,670 2025 9,444 Thereafter 39,252 Total $ 86,026

Debt and Finance Lease Obligati

Debt and Finance Lease Obligations	9 Months Ended
	Jul. 31, 2021
Debt Disclosure [Abstract]
Debt and Finance Lease Obligations	Debt and Finance Lease Obligations Long-term debt consisted of the following at July 31, 2021 and October 31, 2020 (in thousands): July 31, October 31, Revolving Credit Facility $ 58,000 $ 103,000 Finance lease obligations and other 15,951 15,321 Unamortized deferred financing fees (673) (901) Total debt $ 73,278 $ 117,420 Less: Current maturities of long-term debt 839 692 Long-term debt $ 72,439 $ 116,728 Revolving Credit Facility As more fully described in our Annual Report on Form 10-K for the fiscal year ended October 31, 2020, on October 18, 2018, we amended and extended our prior credit facility by entering into a $325.0 million revolving credit facility (the “2018 Credit Facility”), with Wells Fargo Bank, National Association, as Agent, Swingline Lender and Issuing Lender, and Bank of America, N.A. serving as Syndication Agent. The 2018 Credit Facility has a five-year term, maturing on October 18, 2023, and requires interest payments calculated, at our election and depending upon our Consolidated Leverage Ratio, at either a Base Rate plus an applicable margin or the LIBOR Rate plus an applicable margin. As of July 31, 2021, the applicable rate was LIBOR + 1.25%. In addition, we are subject to commitment fees for the unused portion of the 2018 Credit Facility. The applicable margin and commitment fees are outlined in the following table: Pricing Level Consolidated Leverage Ratio Commitment Fee LIBOR Rate Loans Base Rate Loans I Less than or equal to 1.50 to 1.00 0.200% 1.25% 0.25% II Greater than 1.50 to 1.00, but less than or equal to 2.25 to 1.00 0.225% 1.50% 0.50% III Greater than 2.25 to 1.00, but less than or equal to 3.00 to 1.00 0.250% 1.75% 0.75% IV Greater than 3.00 to 1.00 0.300% 2.00% 1.00% In the event of default, outstanding borrowings would accrue interest at the Default Rate, as defined, whereby the obligations will bear interest at a per annum rate equal to 2% above the total per annum rate otherwise applicable. The 2018 Credit Facility provides for incremental revolving credit commitments for a minimum principal amount of $10.0 million, up to an aggregate amount of $150.0 million, subject to the lender's discretion to elect or decline the incremental increase. We can also borrow up to the lesser of $15.0 million or the revolving credit commitment, as defined, under a Swingline feature of the Credit Facility. The 2018 Credit Facility contains a: (1) Consolidated Interest Coverage Ratio requirement whereby we must not permit the Consolidated Interest Coverage Ratio, as defined, to be less than 2.25 to 1.00, and (2) Consolidated Leverage Ratio requirement, whereby we must not permit the Consolidated Leverage Ratio, as defined, to be greater than 3.25 to 1.00. In addition to maintaining these financial covenants, the 2018 Credit Facility also limits our ability to enter into certain business transactions, such as to incur indebtedness or liens, to acquire businesses or dispose of material assets, make restricted payments, pay dividends (limited to $20.0 million per year) and other transactions as further defined in the 2018 Credit Facility. Some of these limitations, however, do not take effect so long as total leverage is less than or equal to 2.75 to 1.00 and available liquidity exceeds $25.0 million. Substantially all of our domestic assets, with the exception of real property, are used as collateral for the Credit Agreement. As of July 31, 2021, we ha d $58.0 million of borrowings outstanding under the 2018 Credit Facility (reduced by unamortized debt issuance costs of $0.7 million), $4.5 million of o utstanding letters of credit and $16.0 million outstanding primarily under finance leases and other debt. We had $262.5 million availa ble for use under the 2018 Credit Facility at July 31, 2021. Outstanding borrowings under the 2018 Credit Facility accrue interes t at 1.34% per annum. Our weighted average borrowing rate for borrowings outstanding during the nine months ended July 31, 2021 and 2020 was 1.43%

Retirement Plans

Retirement Plans	9 Months Ended
	Jul. 31, 2021
Retirement Benefits [Abstract]
Retirement Plans	Retirement Plans Pension Plan Our non-contributory, single employer defined benefit pension plan covers certain of our employees in the U.S. The net periodic pension cost for this plan for the three and nine months ended July 31, 2021 and 2020 was as follows (in thousands): Three Months Ended Nine Months Ended July 31, July 31, 2021 2020 2021 2020 Service cost $ 212 $ 242 $ 637 $ 1,022 Interest cost 189 280 567 853 Expected return on plan assets (490) (509) (1,470) (1,503) Amortization of net loss 36 (4) 108 200 Net periodic pension (benefit) cost $ (53) $ 9 $ (158) $ 572 On January 1, 2020, we enacted changes to our pension plan whereby the benefits for all participants were frozen and thereafter those participants will receive increased benefits in the Company sponsored defined contribution plan in lieu of participation in a defined benefit plan. As a result of this action, we remeasured the pension assets and obligations for the pension plan, which resulted in a decrease to our projected benefit obligation and a corresponding net actuarial gain that was recorded in accumulated other comprehensive income. During September 2020, we contributed $3.7 million to fund our plan, and we expect to make a contribution to our plan in September 2021 of approximately $0.5 million. Other Plans We also have a supplemental benefit plan covering certain executive officers and key employees and a non-qualified deferred compensation plan covering members of the Board of Directors and certain key employees. As of July 31, 2021 and October 31, 2020, our liability under the supplemental benefit plan was approximat ely $2.8 million and $2.6 million, respectively. As of July 31, 2021 and October 31, 2020, the liability associated with the deferred compensation plan was approximately $3.6 million and $3.3 million, respectively. We record the current portion of liabilities as sociated with these plans under the caption “Accrued Liabilities,” and the long-term portion under the caption “Other Liabilities” in the accompanying condensed consolidated balance sheets.

Income Taxes

Income Taxes	9 Months Ended
	Jul. 31, 2021
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes To determine our income tax expense or benefit for interim periods, consistent with accounting standards, we apply the estimated annual effective income tax rate to year-to-date results, adjusted for any applicable discrete items. Our estimated annual effective tax rates from continuing operations for the nine months ended July 31, 2021 and 2020 were 32.5% and 29.7% , respectively. The difference between our effective income tax rate and the U.S. federal statutory rate of 21% principally result from discrete tax items, U.S. state tax, non-U.S. tax rate differential and other permanent differences. The primary discrete items affecting the 2021 effective rate were the $3.1 million measurement of our deferred income tax assets and liabilities related to the increase in the corporate tax rate in the U.K. from 19% to 25%, a charge of $0.6 million related to the vesting or exercise of equity-based compensation awards and a benefit of $0.6 million for the true-up of our accruals and related deferred taxes from prior year filings. The 2020 effective tax rate was primarily impacted by a discrete charge of $0.5 million related to the vesting or exercise of equity-based compensation awards. As of July 31, 2021, our liability for uncertain tax positions (UTP) of $0.5 million relates to certain U.S. state tax items regarding the interpretation of tax laws and regulations, including $0.2 million of interest and penalties. We include all interest and penalties related to uncertain tax benefits within our income tax provision account. Our total unrecognized tax benefits, if recognized, would not materially affect our effective tax rate. We do not believe any of the UTP at July 31, 2021 will be recognized within the next twelve months. We evaluate the likelihood of realization of our deferred tax assets by considering both positive and negative evidence. We maintain a valuation allowance for certain state net operating losses which totaled $1.5 million as of July 31, 2021 and October 31, 2020. Final regulations were published by the Internal Revenue Service regarding Uniform Capitalization (UNICAP) that became effective during fiscal 2020. On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security (CARES) Act was signed into law. In addition, the Consolidated Appropriations Act, 2021 (CAA) was signed into law on December 27, 2020 and the American Rescue Plan Act of 2021 (American Rescue Plan) was signed into law on March 11, 2021. We evaluated the UNICAP regulations and the CARES Act and determined that there were no material impacts on our condensed consolidated financial statements. We are evaluating the CAA and the American Rescue Plan and do not believe there will be a material impact on our condensed consolidated financial statements.

Contingencies

Contingencies	9 Months Ended
	Jul. 31, 2021
Commitments and Contingencies Disclosure [Abstract]
Contingencies	Contingencies Remediation and Environmental Compliance Costs Under applicable state and federal laws, we may be responsible for, among other things, all or part of the costs required to remove or remediate wastes or hazardous substances at locations we, or our predecessors, have owned or operated. From time to time, we also have been alleged to be liable for all or part of the costs incurred to clean up third-party sites where there might have been an alleged improper disposal of hazardous substances. At present, we are not involved in any such matters. From time to time, we incur routine expenses and capital expenditures associated with compliance with existing environmental regulations, including control of air emissions and water discharges, and plant decommissioning costs. We have not incurred any material expenses or capital expenditures related to environmental matters during the past three fiscal years, and do not expect to incur a material amount of such costs in fiscal 2021. While we will continue to have future expenditures related to environmental matters, any such amounts are impossible to reasonably estimate at this time. Based upon our experience to date, we do not believe that our compliance with environmental requirements will have a material adverse effect on our operations, financial condition or cash flows. Litigation From time to time, we, along with our subsidiaries, are involved in various litigation matters arising in the ordinary course of our business, including those arising from or related to contractual matters, commercial disputes, intellectual property, personal injury, environmental matters, product performance or warranties, product liability, insurance coverage and personnel and employment disputes. We regularly review with legal counsel the status of all ongoing proceedings, and we maintain insurance against these risks to the extent deemed prudent by our management and to the extent such insurance is available. However, there is no assurance that we will prevail in these matters or that our insurers will accept full coverage of these matters, and we could, in the future, incur judgments, enter into settlements of claims, or revise our expectations regarding the outcome or insurability of matters we face, which could materially impact our results of operations.

Fair Value Measurement of Asset

Fair Value Measurement of Assets and Liabilities	9 Months Ended
	Jul. 31, 2021
Fair Value Disclosures [Abstract]
Fair Value Measurement of Assets and Liabilities	Fair Value Measurement of Assets and Liabilities Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value hierarchy distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity's own assumptions about market data developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to Level 1 and the lowest priority to Level 3. The three levels of the fair value hierarchy are described below: • Level 1 - Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities. • Level 2 - Inputs other than quoted prices included within Level 1 that are observable for the asset or liability either directly or indirectly including quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates) and inputs that are derived principally from or corroborated by observable market data by correlation or other means. • Level 3 - Inputs that are both significant to the fair value measurement and unobservable. Carrying amounts reported on the balance sheet for cash, cash equivalents, accounts receivable and accounts payable approximate fair value due to the short-term maturity of these instruments. Our outstanding debt is variable rate debt that re-prices frequently, thereby limiting our exposure to significant change in interest rate risk. As a result, the fair value of our debt instrument approximates carrying value at July 31, 2021, and October 31, 2020 (Level 2 measurement). Our performance share awards are marked-to-market on a quarterly basis during a three-year vesting period based on market data (Level 2 measurement). For further information, refer to Note 9, “Stock-Based Compensation - Performance Share Awards.”

Stock-Based Compensation

Stock-Based Compensation	9 Months Ended
	Jul. 31, 2021
Share-based Payment Arrangement [Abstract]
Stock-Based Compensation	Stock-Based Compensation We have established and maintain an Omnibus Incentive Plan (2020 Plan) that provides for the granting of restricted stock awards, stock options, restricted stock units, performance share awards, performance restricted stock units, and other stock-based and cash-based awards. The 2020 Plan is administered by the Compensation and Management Development Committee of the Board of Directors. The aggregate number of shares of common stock authorized for grant under the 2020 Plan is 3,139,895 as approved by shareholders. Any officer, key employee and/or non-employee director is eligible for awards under the 2020 Plan. We grant restricted stock units to non-employee directors on the first business day of each fiscal year. As approved by the Compensation & Management Development Committee of our Board of Directors annually, we grant a mix of restricted stock awards, restricted stock units, performance shares and/or performance restricted stock units to officers, management and key employees. We also historically granted stock options to certain officers, directors and key employees. Occasionally, we may make additional grants to key employees at other times during the year. Restricted Stock Awards Restricted stock awards are granted to key employees and officers annually, and typically cliff vest over a three-year period with service and continued employment as the only vesting criteria. The recipient of the restricted stock award is entitled to all of the rights of a shareholder, except that the award is nontransferable during the vesting period. The fair value of the restricted stock award is established on the grant date and then expensed over the vesting period resulting in an increase in additional paid-in-capital. Shares are generally issued from treasury stock at the time of grant. A summary of non-vested restricted stock awards activity during the nine months ended July 31, 2021 is presented below: Restricted Stock Awards Weighted Average Non-vested at October 31, 2020 187,500 $ 16.82 Granted 73,300 20.68 Forfeited — — Vested (44,400) 20.70 Non-vested at July 31, 2021 216,400 $ 17.28 The total weighted average grant-date fair value of restricted stock awards that vested during each of the nine months ended July 31, 2021 and 2020 was $0.9 million and $1.1 million, respectively. As of July 31, 2021, total unrecognized compensation cost related to unamortized restricted stock awards was $1.8 million. We expect to recognize this expense over the remaining weighted average vesting period of 1.9 years. Stock Options Historically, stock options have been awarded to key employees, officers and non-employee directors. In December 2017, the Compensation & Management Development Committee of the Board of Directors approved a change to the long-term incentive award program eliminating the grant of stock options and replacing this award with a grant of performance restricted stock units as further described below. As a result, the final stock options were granted during the fiscal year ended October 31, 2017. Stock options typically vested ratably over a three-year period with service and continued employment as the vesting conditions. Our stock options may be exercised up to a maximum of ten years from the date of grant. The fair value of the stock options was determined on the grant date and expensed over the vesting period resulting in an increase in additional paid-in-capital. For employees who were nearing retirement-eligibility, we recognized stock option expense ratably over the shorter of the vesting period or the period from the grant-date to the retirement-eligibility date. We use a Black-Scholes pricing model to estimate the fair value of stock options. A description of the methodology for the valuation assumptions was disclosed in our Annual Report on Form 10-K for the fiscal year ended October 31, 2020. The following table summarizes our stock option activity for the nine months ended July 31, 2021: Stock Options Weighted Average Weighted Average Aggregate Outstanding at October 31, 2020 1,095,329 $ 18.88 Granted — $ — Exercised (865,393) 18.80 Forfeited/Expired (2,500) 18.22 Outstanding at July 31, 2021 227,436 $ 19.20 3.5 $ 1,283 Vested at July 31, 2021 227,436 $ 19.20 3.5 $ 1,283 Exercisable at July 31, 2021 227,436 $ 19.20 3.5 $ 1,283 Intrinsic value is the amount by which the market price of the common stock on the date of exercise exceeds the exercise price of the stock option. The total intrinsic value of stock options exercised during the nine months ended July 31, 2021 and 2020 was $4.2 million and $0.5 million, respectively. The weighted-average grant date fair value of stock options that vested during the nine months ended July 31, 2020 was $0.4 million. Restricted Stock Units Restricted stock units may be awarded to key employees and officers from time to time, and annually to non-employee directors. The non-employee director restricted stock units vest immediately but are payable only upon the director's cessation of service unless an election is made by the non-employee director to settle and pay the award on an earlier specified date. Restricted stock units awarded to employees and officers typically cliff vest after a three-year period with service and continued employment as the vesting conditions. Restricted stock units are not considered outstanding shares and do not have voting rights, although the holder does receive a cash payment equivalent to the dividend paid, on a one-for-one basis, on our outstanding common shares. Once the criteria is met, each restricted stock unit is payable to the holder in cash based on the market value of one share of our common stock. Accordingly, we record a liability for the restricted stock units on our balance sheet and recognize any changes in the market value during each reporting period as compensation expense. During the nine months ended July 31, 2021 and 2020, non-employee directors received 28,826 and 25,326 restricted stock units, respectively, at a grant date fair value of $18.79 per share and $19.02 per share, respectively, which vested immediately. As of July 31, 2021, there were 21,774 non-vested restricted stock units, which were awarded in January 2020 to key employees at a weighted average grant date fair value of $17.08. During the nine months ended July 31, 2021 we paid $0.8 million to settle vested restricted stock units. There were no corresponding payments to settle vested restricted stock during the nine months ended July 31, 2020. Performance Share Awards We have awarded annual grants of performance shares to key employees and officers. Beginning with the fiscal year ended October 31, 2019, performance share awards vest with return on net assets (RONA) as the vesting condition and pay out 100% in cash, and are accounted for as liability. The expected cash settlement of the performance share award is recorded as a liability and is being marked to market over the three-year term of the award and can fluctuate depending on the number of shares ultimately expected to vest. Depending on the achievement of the performance conditions, 0% to 200% of the awarded performance shares may ultimately vest. The following table summarizes our performance share grants and the grant date fair value for the RONA performance metrics: Grant Date Shares Awarded Grant Date Fair Value Shares Forfeited December 5, 2018 132,400 $ 13.63 40,900 December 5, 2019 55,900 $ 19.40 5,300 December 2, 2020 65,300 $ 20.68 — In December 2020, the December 2017 grant vested, however, no shares were awarded as performance criteria were not met. We recorded compensation exp ense of $0.7 million and $4.0 million, respectively, for the three and nine months ended July 31, 2021 related to the expected payout of our performance share awards that w ere outstanding as of July 31, 2021. We recorded compensation expense of $0.1 million for the three months ended July 31, 2020 and a decrease in compensation expense of $0.3 million for the nine months ended July 31, 2020 related to the expected payout of our performance share awards that were outstanding as of July 31, 2020. Performance share awards are payable in cash based upon the number of performance shares ultimately earned, and are therefore not considered outstanding shares. Performance Restricted Stock Units We award performance restricted stock units to key employees and officers. These awards cliff vest upon a three-year service period with the absolute total shareholder return of our common stock over this three-year term as the vesting criteria. The number of shares earned is variable depending on the metric achieved, and the settlement method is 100% in our common stock, with accrued dividends paid in cash at the time of vesting, assuming the shares had been outstanding throughout the performance period. To value the performance restricted stock units, we used a Monte Carlo simulation model to arrive at a grant-date fair value. This amount will be adjusted for forfeitures and expensed over the three-year term of the award with a credit to additional paid-in-capital. Depending on the achievement of the performance conditions, a minimum of 0% and a maximum of 150% of the awarded performance restricted stock units may vest. Specifically, the awards vest on a continuum with the following Absolute Total Shareholder Return (A-TSR) milestones: Vesting Level Vesting Criteria Percentage of Award Vested Level 1 A-TSR greater than or equal to 50% 150% Level 2 A-TSR less than 50% and greater than or equal to 20% 100% Level 3 A-TSR less than 20% and greater than or equal to -20% 50% Level 4 A-TSR less than -20% —% The following table summarizes our performance restricted stock unit grants and the grant date fair value for the A-TSR performance metric: Grant Date Shares Awarded Grant Date Fair Value Shares Forfeited December 5, 2018 89,200 $ 13.63 25,500 December 5, 2019 35,000 $ 19.40 — December 2, 2020 38,400 $ 20.68 — During the nine months ended July 31, 2021 , 32,322 performance restricted stock units vested. We recorded compensation expense related to our performance restricted stock units of approximately $0.1 million and $0.5 million, respectively, for the three and nine months ending July 31, 2021 and $0.1 million and $0.4 million, respectively, for the comparable prior year periods. The performance restricted stock units are not considered outstanding shares, do not have voting rights, and are exclud ed from diluted weighted-average shares used to calculate earnings per share until the performance criteria is probable to result in the issuance of contingent shares. As of July 31, 2021, we have de emed 92,104 shares related to the December 2018 grant of performance restricted stock units as probable to vest. Treasury Shares We record treasury stock purchases under the cost method whereby the entire cost of the acquired stock is recorded as treasury stock. Shares are generally issued from treasury stock at the time of grant of restricted stock awards, upon the exercise of stock options, and upon the vesting of performance shares and performance restricted stock units. On the subsequent issuance of treasury shares, we record proceeds in excess of cost as an increase in additional paid in capital. A deficiency of such proceeds relative to costs would be applied to reduce paid-in-capital associated with prior issuances to the extent available, with the remainder recorded as a charge to retained earnings. There were no charges to retained earnings during the nine months ended July 31, 2021. The following table summarizes the treasury stock activity during the nine months ended July 31, 2021: Nine Months Ended July 31, 2021 Beginning Balance as of November 1, 2020 4,491,429 Restricted stock awards granted (73,300) Performance restricted stock units vested (32,322) Stock options exercised (865,393) Treasury stock repurchases 231,308 Balance at July 31, 2021 3,751,722

Other, net

Other, net	9 Months Ended
	Jul. 31, 2021
Other Income and Expenses [Abstract]
Other Income	Other, net Other, net on the condensed consolidated statements of income consisted of the following for the three and nine months ended July 31, 2021 and 2020 (in thousands): Three Months Ended Nine Months Ended July 31, July 31, 2021 2020 2021 2020 Foreign currency transaction losses $ (79) $ (458) $ (161) $ (375) Foreign currency derivative losses — — — (15) Pension service benefit 265 232 795 449 Interest income — 5 4 24 Other 2 1 7 33 Other, net $ 188 $ (220) $ 645 $ 116

Segment Information

Segment Information	9 Months Ended
	Jul. 31, 2021
Segment Reporting [Abstract]
Segment Information	Segment Information We present three reportable business segments (1) NA Fenestration, comprising three operating segments primarily focused on the fenestration market in North America including vinyl profiles, insulating glass spacers, screens & other fenestration components; (2) EU Fenestration, comprising our U.K.-based vinyl extrusion business, manufacturing vinyl profiles & conservatories, and the European insulating glass business manufacturing insulating glass spacers; and (3) NA Cabinet Components, comprising our cabinet door and components operations. We maintain an Unallocated Corporate & Other which includes transaction expenses, stock-based compensation, long-term incentive awards based on the performance of our common stock and other factors, certain severance, legal, and other costs not deemed to be allocable to all segments, depreciation of corporate assets, interest expense, other, net, income taxes and inter-segment eliminations, and executive incentive compensation and medical expense fluctuations relative to planned costs as determined during the annual planning process. Other general and administrative costs associated with the corporate office are allocated to the reportable segments, based upon a relative measure of profitability in order to more accurately reflect each reportable business segment's administrative costs. We allocate corporate expenses to businesses acquired mid-year from the date of acquisition. The accounting polic ies of our operating segments are the same as those used to prepare the accompanying condensed consolidated financial statements. Corporate general and administrative expense allocated during the three and nine month period ended July 31, 2021 was $4.9 million and $15.6 million, respectively, and $5.2 million and $15.4 million for the comparable prior year periods. ASC Topic 280-10-50, “Segment Reporting” (ASC 280) permits aggregation of operating segments based on factors including, but not limited to: (1) similar nature of products serving the building products industry, primarily the fenestration business; (2) similar production processes, although there are some differences in the amount of automation amongst operating plants; (3) similar types or classes of customers, namely the primary OEMs; (4) similar distribution methods for product delivery, although the extent of the use of third-party distributors will vary amongst the businesses; (5) similar regulatory environment; and (6) converging long-term economic similarities. Segment information for the three and nine months ended July 31, 2021 and 2020, and total assets as of July 31, 2021 and October 31, 2020 are summarized in the following table (in thousands): NA Fenestration EU Fenestration NA Cabinet Comp. Unallocated Corp. & Other Total Three Months Ended July 31, 2021 Net sales $ 147,818 $ 71,114 $ 61,936 $ (991) $ 279,877 Depreciation and amortization 4,571 2,646 3,390 76 10,683 Operating income (loss) 13,302 11,464 (918) (2,286) 21,562 Capital expenditures 2,651 2,285 1,115 156 6,207 Three Months Ended July 31, 2020 Net sales $ 122,386 $ 38,265 $ 51,925 $ (480) $ 212,096 Depreciation and amortization 5,371 2,307 3,264 118 11,060 Operating income (loss) 12,383 5,365 (193) (992) 16,563 Capital expenditures 1,963 1,787 602 8 4,360 Nine Months Ended July 31, 2021 Net sales $ 422,077 $ 181,862 $ 179,492 $ (3,050) $ 780,381 Depreciation and amortization 14,528 7,771 9,965 279 32,543 Operating income (loss) 40,288 29,901 (1,215) (14,197) 54,777 Capital expenditures 7,472 4,025 4,228 281 16,006 Nine Months Ended July 31, 2020 Net sales $ 341,432 $ 104,230 $ 152,634 $ (2,128) $ 596,168 Depreciation and amortization 18,311 7,045 10,139 356 35,851 Operating income (loss) 21,442 9,140 (3,481) 335 27,436 Capital expenditures 13,199 3,413 3,946 115 20,673 As of July 31, 2021 Total assets $ 264,286 $ 244,381 $ 176,625 $ 33,900 $ 719,192 As of October 31, 2020 Total assets $ 252,703 $ 223,248 $ 174,713 $ 40,921 $ 691,585 The following table summarizes the change in the carrying amount of goodwill by reportable business segment for the nine months ended July 31, 2021 (in thousands): NA Fenestration EU Fenestration NA Cabinet Comp. Unallocated Corp. & Other Total Balance as of October 31, 2020 $ 38,712 $ 68,295 $ 39,147 $ — $ 146,154 Foreign currency translation adjustment — 4,333 — — 4,333 Balance as of July 31, 2021 $ 38,712 $ 72,628 $ 39,147 $ — $ 150,487 For further details of Goodwill, see Note 3, “Goodwill & Intangible Assets”, located herewith. We did not allocate non-operating loss or income tax benefit to the reportable segments. The following table reconciles operating income as reported above to net income for the three and nine months ended July 31, 2021 and 2020 (in thousands): Three Months Ended Nine Months Ended July 31, July 31, 2021 2020 2021 2020 Operating income $ 21,562 $ 16,563 $ 54,777 $ 27,436 Interest expense (597) (1,165) (1,988) (4,310) Other, net 188 (220) 645 116 Income tax expense (7,474) (4,345) (17,352) (6,898) Net income $ 13,679 $ 10,833 $ 36,082 $ 16,344

Earnings Per Share

Earnings Per Share	9 Months Ended
	Jul. 31, 2021
Earnings Per Share [Abstract]
Earnings Per Share	Earnings Per ShareWe compute basic earnings per share by dividing net income by the weighted average number of common shares outstanding during the period. Diluted earnings per common and potential common shares include the weighted average of additional shares associated with the incremental effect of dilutive employee stock options, non-vested restricted stock as determined using the treasury stock method prescribed by U.S. GAAP and contingent shares associated with performance share awards, if dilutive. Basic and diluted earnings per share for the three and nine months ended July 31, 2021 and 2020 were calculated as follows (in thousands, except per share data): Net Income Weighted Average Shares Per Share Three Months Ended July 31, 2021 Basic earnings per common share $ 13,679 33,359 $ 0.41 Effect of dilutive securities: Stock options — 59 — Restricted stock awards — 140 — Performance restricted stock units — 92 — Diluted earnings per common share $ 13,679 33,650 $ 0.41 Three Months Ended July 31, 2020 Basic earnings per common share $ 10,833 32,610 $ 0.33 Effect of dilutive securities: Stock options — 1 — Restricted stock awards — 86 — Performance shares — 17 — Performance restricted stock units — 25 — Diluted earnings per common share $ 10,833 32,739 $ 0.33 Nine Months Ended July 31, 2021 Basic earnings per common share $ 36,082 33,194 $ 1.09 Effect of dilutive securities: Stock options — 103 — Restricted stock awards — 129 — Performance restricted stock units — 92 — Diluted earnings per common share $ 36,082 33,518 $ 1.08 Nine Months Ended July 31, 2020 Basic earnings per common share $ 16,344 32,716 $ 0.50 Effect of dilutive securities: Stock options — 5 — Restricted stock awards — 82 — Performance shares — 17 — Performance restricted stock units — 25 — Diluted earnings per common share $ 16,344 32,845 $ 0.50 We do not include equity instruments in our calculation of diluted earnings per share if those instruments would be anti-dilutive. Such dilution is dependent on the excess of the market price of our stock over the exercise price and other components of the treasury stock method. The following table shows anti-dilutive instruments for the three and nine months ended July 31, 2021 and 2020 (shares in thousands): Three Months Ended Nine Months Ended July 31, July 31, 2021 2020 2021 2020 Stock options — 1,139 — 1,107 Restricted stock awards — 51 — 51 Total — 1,190 — 1,158

New Accounting Guidance

New Accounting Guidance	9 Months Ended
	Jul. 31, 2021
Accounting Changes and Error Corrections [Abstract]
New Accounting Guidance	New Accounting Guidance Accounting Standards Recently Adopted In June 2016, the Financial Accounting Standards Board issued Accounting Standards Update No. 2016-13, Financial Instruments - Credit Losses (Topic 326) . This ASU sets forth a “current expected credit loss” model, which requires the measurement of all expected credit losses for financial instruments or other assets (e.g., trade receivables), held at the reporting date based on historical experience, current conditions, and reasonable supportable forecasts. We adopted this amendment on November 1, 2020, with no material impact on our condensed consolidated financial statements.

Nature of Operations and Basi_2

Nature of Operations and Basis of Presentation (Tables)	9 Months Ended
	Jul. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Disaggregation of Revenue	Three Months Ended Nine Months Ended July 31, July 31, 2021 2020 2021 2020 (In thousands) North American Fenestration: United States - fenestration $ 129,291 $ 109,455 $ 369,809 $ 302,094 International - fenestration 9,581 6,696 25,756 19,284 United States - non-fenestration 5,853 4,845 17,543 13,779 International - non-fenestration 3,093 1,390 8,969 6,275 $ 147,818 $ 122,386 $ 422,077 $ 341,432 European Fenestration: International - fenestration $ 54,883 $ 31,904 $ 147,072 87,732 International - non-fenestration 16,231 6,361 34,790 16,498 $ 71,114 $ 38,265 $ 181,862 $ 104,230 North American Cabinet Components: United States - fenestration $ 3,240 $ 2,666 $ 9,711 $ 8,461 United States - non-fenestration 57,418 48,849 168,308 142,838 International - non-fenestration 1,278 410 1,473 1,335 $ 61,936 $ 51,925 $ 179,492 $ 152,634 Unallocated Corporate & Other Eliminations $ (991) $ (480) $ (3,050) $ (2,128) $ (991) $ (480) $ (3,050) $ (2,128) Net sales $ 279,877 $ 212,096 $ 780,381 $ 596,168

Inventories (Tables)

Inventories (Tables)	9 Months Ended
	Jul. 31, 2021
Inventory Disclosure [Abstract]
Inventories	Inventories consisted of the following at July 31, 2021 and October 31, 2020 (in thousands): July 31, October 31, Raw materials $ 46,810 $ 33,298 Finished goods and work in process 45,728 32,347 Supplies and other 2,459 2,020 Total 94,997 67,665 Less: Inventory reserves 1,504 6,484 Inventories, net $ 93,493 $ 61,181

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	9 Months Ended
	Jul. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Changes in the Carrying Amount of Goodwill	The change in the carrying amount of goodwill for the nine months ended July 31, 2021 was as follows (in thousands): Nine Months Ended July 31, 2021 Beginning balance as of November 1, 2020 $ 146,154 Foreign currency translation adjustment 4,333 Balance as of the end of the period $ 150,487 The following table summarizes the change in the carrying amount of goodwill by reportable business segment for the nine months ended July 31, 2021 (in thousands): NA Fenestration EU Fenestration NA Cabinet Comp. Unallocated Corp. & Other Total Balance as of October 31, 2020 $ 38,712 $ 68,295 $ 39,147 $ — $ 146,154 Foreign currency translation adjustment — 4,333 — — 4,333 Balance as of July 31, 2021 $ 38,712 $ 72,628 $ 39,147 $ — $ 150,487
Schedule of Acquired Finite-Lived Intangible Assets by Major Class	Identifiable Intangible Assets Amortizable intangible assets consisted of the following as of July 31, 2021 and October 31, 2020 (in thousands): July 31, 2021 October 31, 2020 Gross Carrying Accumulated Gross Carrying Accumulated Customer relationships $ 146,850 $ 78,785 $ 154,004 $ 80,441 Trademarks and trade names 56,635 39,164 55,745 37,314 Patents and other technology 22,546 22,056 22,386 21,312 Total $ 226,031 $ 140,005 $ 232,135 $ 139,067
Estimated Amortization Expense Related to Intangible Assets	Estimated remaining amortization expense, based on current intangible balances, for each of the fiscal years ending October 31, is as follows (in thousands): Estimated 2021 (remaining three months) $ 3,057 2022 12,181 2023 11,422 2024 10,670 2025 9,444 Thereafter 39,252 Total $ 86,026

Debt and Finance Lease Obliga_2

Debt and Finance Lease Obligations (Tables)	9 Months Ended
	Jul. 31, 2021
Debt Disclosure [Abstract]
Debt and Finance Lease Obligations	Long-term debt consisted of the following at July 31, 2021 and October 31, 2020 (in thousands): July 31, October 31, Revolving Credit Facility $ 58,000 $ 103,000 Finance lease obligations and other 15,951 15,321 Unamortized deferred financing fees (673) (901) Total debt $ 73,278 $ 117,420 Less: Current maturities of long-term debt 839 692 Long-term debt $ 72,439 $ 116,728
Schedule of Applicable Margin and Commitment Fees	The applicable margin and commitment fees are outlined in the following table: Pricing Level Consolidated Leverage Ratio Commitment Fee LIBOR Rate Loans Base Rate Loans I Less than or equal to 1.50 to 1.00 0.200% 1.25% 0.25% II Greater than 1.50 to 1.00, but less than or equal to 2.25 to 1.00 0.225% 1.50% 0.50% III Greater than 2.25 to 1.00, but less than or equal to 3.00 to 1.00 0.250% 1.75% 0.75% IV Greater than 3.00 to 1.00 0.300% 2.00% 1.00%

Retirement Plans (Tables)

Retirement Plans (Tables)	9 Months Ended
	Jul. 31, 2021
Retirement Benefits [Abstract]
Net Periodic Pension Cost	The net periodic pension cost for this plan for the three and nine months ended July 31, 2021 and 2020 was as follows (in thousands): Three Months Ended Nine Months Ended July 31, July 31, 2021 2020 2021 2020 Service cost $ 212 $ 242 $ 637 $ 1,022 Interest cost 189 280 567 853 Expected return on plan assets (490) (509) (1,470) (1,503) Amortization of net loss 36 (4) 108 200 Net periodic pension (benefit) cost $ (53) $ 9 $ (158) $ 572

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	9 Months Ended
	Jul. 31, 2021
Share-based Payment Arrangement [Abstract]
Schedule of Nonvested Restricted Share Activity	A summary of non-vested restricted stock awards activity during the nine months ended July 31, 2021 is presented below: Restricted Stock Awards Weighted Average Non-vested at October 31, 2020 187,500 $ 16.82 Granted 73,300 20.68 Forfeited — — Vested (44,400) 20.70 Non-vested at July 31, 2021 216,400 $ 17.28
Schedule of Stock Option Activity	The following table summarizes our stock option activity for the nine months ended July 31, 2021: Stock Options Weighted Average Weighted Average Aggregate Outstanding at October 31, 2020 1,095,329 $ 18.88 Granted — $ — Exercised (865,393) 18.80 Forfeited/Expired (2,500) 18.22 Outstanding at July 31, 2021 227,436 $ 19.20 3.5 $ 1,283 Vested at July 31, 2021 227,436 $ 19.20 3.5 $ 1,283 Exercisable at July 31, 2021 227,436 $ 19.20 3.5 $ 1,283
Schedule of Performance Share Awards	The following table summarizes our performance share grants and the grant date fair value for the RONA performance metrics: Grant Date Shares Awarded Grant Date Fair Value Shares Forfeited December 5, 2018 132,400 $ 13.63 40,900 December 5, 2019 55,900 $ 19.40 5,300 December 2, 2020 65,300 $ 20.68 —
Schedule of Performance Restricted Stock Vesting Conditions	Specifically, the awards vest on a continuum with the following Absolute Total Shareholder Return (A-TSR) milestones: Vesting Level Vesting Criteria Percentage of Award Vested Level 1 A-TSR greater than or equal to 50% 150% Level 2 A-TSR less than 50% and greater than or equal to 20% 100% Level 3 A-TSR less than 20% and greater than or equal to -20% 50% Level 4 A-TSR less than -20% —%
Performance Restricted Stock Units by Grant	Grant Date Shares Awarded Grant Date Fair Value Shares Forfeited December 5, 2018 89,200 $ 13.63 25,500 December 5, 2019 35,000 $ 19.40 — December 2, 2020 38,400 $ 20.68 —
Treasury Stock Activity	The following table summarizes the treasury stock activity during the nine months ended July 31, 2021: Nine Months Ended July 31, 2021 Beginning Balance as of November 1, 2020 4,491,429 Restricted stock awards granted (73,300) Performance restricted stock units vested (32,322) Stock options exercised (865,393) Treasury stock repurchases 231,308 Balance at July 31, 2021 3,751,722

Other, net (Tables)

Other, net (Tables)	9 Months Ended
	Jul. 31, 2021
Other Income and Expenses [Abstract]
Schedule of Other Non-operating Income (Expense)	Other, net Other, net on the condensed consolidated statements of income consisted of the following for the three and nine months ended July 31, 2021 and 2020 (in thousands): Three Months Ended Nine Months Ended July 31, July 31, 2021 2020 2021 2020 Foreign currency transaction losses $ (79) $ (458) $ (161) $ (375) Foreign currency derivative losses — — — (15) Pension service benefit 265 232 795 449 Interest income — 5 4 24 Other 2 1 7 33 Other, net $ 188 $ (220) $ 645 $ 116

Segment Information (Tables)

Segment Information (Tables)	9 Months Ended
	Jul. 31, 2021
Segment Reporting [Abstract]
Schedule of Segment Reporting Information, by Segment	Segment information for the three and nine months ended July 31, 2021 and 2020, and total assets as of July 31, 2021 and October 31, 2020 are summarized in the following table (in thousands): NA Fenestration EU Fenestration NA Cabinet Comp. Unallocated Corp. & Other Total Three Months Ended July 31, 2021 Net sales $ 147,818 $ 71,114 $ 61,936 $ (991) $ 279,877 Depreciation and amortization 4,571 2,646 3,390 76 10,683 Operating income (loss) 13,302 11,464 (918) (2,286) 21,562 Capital expenditures 2,651 2,285 1,115 156 6,207 Three Months Ended July 31, 2020 Net sales $ 122,386 $ 38,265 $ 51,925 $ (480) $ 212,096 Depreciation and amortization 5,371 2,307 3,264 118 11,060 Operating income (loss) 12,383 5,365 (193) (992) 16,563 Capital expenditures 1,963 1,787 602 8 4,360 Nine Months Ended July 31, 2021 Net sales $ 422,077 $ 181,862 $ 179,492 $ (3,050) $ 780,381 Depreciation and amortization 14,528 7,771 9,965 279 32,543 Operating income (loss) 40,288 29,901 (1,215) (14,197) 54,777 Capital expenditures 7,472 4,025 4,228 281 16,006 Nine Months Ended July 31, 2020 Net sales $ 341,432 $ 104,230 $ 152,634 $ (2,128) $ 596,168 Depreciation and amortization 18,311 7,045 10,139 356 35,851 Operating income (loss) 21,442 9,140 (3,481) 335 27,436 Capital expenditures 13,199 3,413 3,946 115 20,673 As of July 31, 2021 Total assets $ 264,286 $ 244,381 $ 176,625 $ 33,900 $ 719,192 As of October 31, 2020 Total assets $ 252,703 $ 223,248 $ 174,713 $ 40,921 $ 691,585
Changes in the Carrying Amount of Goodwill	The change in the carrying amount of goodwill for the nine months ended July 31, 2021 was as follows (in thousands): Nine Months Ended July 31, 2021 Beginning balance as of November 1, 2020 $ 146,154 Foreign currency translation adjustment 4,333 Balance as of the end of the period $ 150,487 The following table summarizes the change in the carrying amount of goodwill by reportable business segment for the nine months ended July 31, 2021 (in thousands): NA Fenestration EU Fenestration NA Cabinet Comp. Unallocated Corp. & Other Total Balance as of October 31, 2020 $ 38,712 $ 68,295 $ 39,147 $ — $ 146,154 Foreign currency translation adjustment — 4,333 — — 4,333 Balance as of July 31, 2021 $ 38,712 $ 72,628 $ 39,147 $ — $ 150,487
Reconciliation of Operating Profit (Loss) from Segments to Consolidated	We did not allocate non-operating loss or income tax benefit to the reportable segments. The following table reconciles operating income as reported above to net income for the three and nine months ended July 31, 2021 and 2020 (in thousands): Three Months Ended Nine Months Ended July 31, July 31, 2021 2020 2021 2020 Operating income $ 21,562 $ 16,563 $ 54,777 $ 27,436 Interest expense (597) (1,165) (1,988) (4,310) Other, net 188 (220) 645 116 Income tax expense (7,474) (4,345) (17,352) (6,898) Net income $ 13,679 $ 10,833 $ 36,082 $ 16,344

Earnings Per Share (Tables)

Earnings Per Share (Tables)	9 Months Ended
	Jul. 31, 2021
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted	Basic and diluted earnings per share for the three and nine months ended July 31, 2021 and 2020 were calculated as follows (in thousands, except per share data): Net Income Weighted Average Shares Per Share Three Months Ended July 31, 2021 Basic earnings per common share $ 13,679 33,359 $ 0.41 Effect of dilutive securities: Stock options — 59 — Restricted stock awards — 140 — Performance restricted stock units — 92 — Diluted earnings per common share $ 13,679 33,650 $ 0.41 Three Months Ended July 31, 2020 Basic earnings per common share $ 10,833 32,610 $ 0.33 Effect of dilutive securities: Stock options — 1 — Restricted stock awards — 86 — Performance shares — 17 — Performance restricted stock units — 25 — Diluted earnings per common share $ 10,833 32,739 $ 0.33 Nine Months Ended July 31, 2021 Basic earnings per common share $ 36,082 33,194 $ 1.09 Effect of dilutive securities: Stock options — 103 — Restricted stock awards — 129 — Performance restricted stock units — 92 — Diluted earnings per common share $ 36,082 33,518 $ 1.08 Nine Months Ended July 31, 2020 Basic earnings per common share $ 16,344 32,716 $ 0.50 Effect of dilutive securities: Stock options — 5 — Restricted stock awards — 82 — Performance shares — 17 — Performance restricted stock units — 25 — Diluted earnings per common share $ 16,344 32,845 $ 0.50
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	We do not include equity instruments in our calculation of diluted earnings per share if those instruments would be anti-dilutive. Such dilution is dependent on the excess of the market price of our stock over the exercise price and other components of the treasury stock method. The following table shows anti-dilutive instruments for the three and nine months ended July 31, 2021 and 2020 (shares in thousands): Three Months Ended Nine Months Ended July 31, July 31, 2021 2020 2021 2020 Stock options — 1,139 — 1,107 Restricted stock awards — 51 — 51 Total — 1,190 — 1,158

Nature of Operations and Basi_3

Nature of Operations and Basis of Presentation Summary of Product Sales (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 31, 2021	Jul. 31, 2020	Jul. 31, 2021	Jul. 31, 2020
Product Information [Line Items]
Total sales	$ 279,877	$ 212,096	$ 780,381	$ 596,168
Operating Segments | NA Fenestration
Product Information [Line Items]
Total sales	147,818	122,386	422,077	341,432
Operating Segments | NA Fenestration | United States | Fenestration [Member]
Product Information [Line Items]
Total sales	129,291	109,455	369,809	302,094
Operating Segments | NA Fenestration | United States | Non-fenestration [Member]
Product Information [Line Items]
Total sales	5,853	4,845	17,543	13,779
Operating Segments | NA Fenestration | International | Fenestration [Member]
Product Information [Line Items]
Total sales	9,581	6,696	25,756	19,284
Operating Segments | NA Fenestration | International | Non-fenestration [Member]
Product Information [Line Items]
Total sales	3,093	1,390	8,969	6,275
Operating Segments | EU Fenestration
Product Information [Line Items]
Total sales	71,114	38,265	181,862	104,230
Operating Segments | EU Fenestration | International | Fenestration [Member]
Product Information [Line Items]
Total sales	54,883	31,904	147,072	87,732
Operating Segments | EU Fenestration | International | Non-fenestration [Member]
Product Information [Line Items]
Total sales	16,231	6,361	34,790	16,498
Operating Segments | NA Cabinet Components
Product Information [Line Items]
Total sales	61,936	51,925	179,492	152,634
Operating Segments | NA Cabinet Components | United States | Fenestration [Member]
Product Information [Line Items]
Total sales	3,240	2,666	9,711	8,461
Operating Segments | NA Cabinet Components | United States | Non-fenestration [Member]
Product Information [Line Items]
Total sales	57,418	48,849	168,308	142,838
Operating Segments | NA Cabinet Components | International | Non-fenestration [Member]
Product Information [Line Items]
Total sales	1,278	410	1,473	1,335
Corporate Non-Segment
Product Information [Line Items]
Total sales	$ (991)	$ (480)	$ (3,050)	$ (2,128)

Inventories (Detail)

Inventories (Detail) - USD ($) $ in Thousands	Jul. 31, 2021	Oct. 31, 2020
Inventory, Raw Materials and Supplies, Net of Reserves [Abstract]
Raw materials	$ 46,810	$ 33,298
Finished goods and work in process	45,728	32,347
Supplies and other	2,459	2,020
Total	94,997	67,665
Less: Inventory reserves	1,504	6,484
Inventories, net	$ 93,493	$ 61,181

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets - Goodwill (Details)	Aug. 31, 2020USD ($)reporting_unit	Jul. 31, 2021USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
Number of reporting units | reporting_unit	5
Goodwill, impairment loss	$ 0
Goodwill [Roll Forward]
Beginning balance		$ 146,154,000
Foreign currency translation adjustment		4,333,000
Balance as of the end of the period		$ 150,487,000

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets - Identifiable Intangible Assets (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 31, 2021	Jul. 31, 2020	Jul. 31, 2021	Jul. 31, 2020	Oct. 31, 2020
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	$ 226,031		$ 226,031		$ 232,135
Accumulated amortization	140,005		140,005		139,067
Intangible assets amortization expense	3,000	$ 3,400	9,700	$ 10,800
Estimated Amortization Expense
2021 (remaining three months)	3,057		3,057
2022	12,181		12,181
2023	11,422		11,422
2024	10,670		10,670
2025	9,444		9,444
Thereafter	39,252		39,252
Total	86,026		86,026		93,068
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	146,850		146,850		154,004
Accumulated amortization	78,785		78,785		80,441
Retirement of fully amortized intangibles			9,900
Trademarks and trade names
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	56,635		56,635		55,745
Accumulated amortization	39,164		39,164		37,314
Patents and other technology
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	22,546		22,546		22,386
Accumulated amortization	$ 22,056		$ 22,056		$ 21,312

Debt and Finance Lease Obliga_3

Debt and Finance Lease Obligations (Details) - USD ($)	9 Months Ended
	Jul. 31, 2021	Jul. 31, 2020	Oct. 31, 2020	Oct. 18, 2018
Debt Instrument [Line Items]
Unamortized deferred financing fees	$ 673,000		$ 901,000
Total debt	73,278,000		117,420,000
Current maturities of long-term debt	839,000		692,000
Long-term Debt	72,439,000		116,728,000
Letters of credit, outstanding	4,500,000
Finance lease obligations and other	16,000,000
Credit Facility, amount available	$ 262,500,000
Debt Instrument, Interest Rate During Period	1.43%	2.62%
Term Loan Facility [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	1.34%
Capital Lease Obligations
Debt Instrument [Line Items]
Total debt	$ 15,951,000		15,321,000
Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Revolving Credit Facility	58,000,000
Total debt	$ 58,000,000		$ 103,000,000
2018 Credit Facility [Member] | Line of Credit [Member]
Debt Instrument [Line Items]
Default interest rate	2.00%
Minimum Incremental Borrowing	$ 10,000,000
Maximum Incremental Borrowing	$ 150,000,000
Debt Instrument, Required Coverage Ratio	0.0225
Debt Instrument, Required Leverage Ratio	0.0325
Debt Instrument, Limitation on Annual Dividend	$ 20,000,000
Debt Instrument, Leverage Ratio Threshold for Limitations to Take Effect	2.75
Debt Instrument, Liquidity Threshold for Limitations to Take Effect	$ 25,000,000
2018 Credit Facility [Member] | Line of Credit [Member] | Less than or equal to 1.50 to 1.00
Debt Instrument [Line Items]
Commitment fee percentage	0.20%
2018 Credit Facility [Member] | Line of Credit [Member] | Greater than 1.50 to 1.00, but less than or equal to 2.25 to 1.00
Debt Instrument [Line Items]
Commitment fee percentage	0.225%
2018 Credit Facility [Member] | Line of Credit [Member] | Greater than 2.25 to 1.00, but less than or equal to 3.00 to 1.00
Debt Instrument [Line Items]
Commitment fee percentage	0.25%
2018 Credit Facility [Member] | Line of Credit [Member] | Greater than 3.00 to 1.00
Debt Instrument [Line Items]
Commitment fee percentage	0.30%
Revolving Credit Facility [Member] | Line of Credit [Member]
Debt Instrument [Line Items]
Line of credit facility, maximum borrowing capacity				$ 325,000,000
Swing Line [Member] | Line of Credit [Member]
Debt Instrument [Line Items]
Debt Instrument, Unused Borrowing Capacity, Amount	$ 15,000,000
Base Rate [Member] | 2018 Credit Facility [Member] | Line of Credit [Member] | Less than or equal to 1.50 to 1.00
Debt Instrument [Line Items]
Basis spread on variable rate	0.25%
Base Rate [Member] | 2018 Credit Facility [Member] | Line of Credit [Member] | Greater than 1.50 to 1.00, but less than or equal to 2.25 to 1.00
Debt Instrument [Line Items]
Basis spread on variable rate	0.50%
Base Rate [Member] | 2018 Credit Facility [Member] | Line of Credit [Member] | Greater than 2.25 to 1.00, but less than or equal to 3.00 to 1.00
Debt Instrument [Line Items]
Basis spread on variable rate	0.75%
Base Rate [Member] | 2018 Credit Facility [Member] | Line of Credit [Member] | Greater than 3.00 to 1.00
Debt Instrument [Line Items]
Basis spread on variable rate	1.00%
London Interbank Offered Rate (LIBOR) [Member] | 2018 Credit Facility [Member] | Line of Credit [Member] | Less than or equal to 1.50 to 1.00
Debt Instrument [Line Items]
Basis spread on variable rate	1.25%
London Interbank Offered Rate (LIBOR) [Member] | 2018 Credit Facility [Member] | Line of Credit [Member] | Greater than 1.50 to 1.00, but less than or equal to 2.25 to 1.00
Debt Instrument [Line Items]
Basis spread on variable rate	1.50%
London Interbank Offered Rate (LIBOR) [Member] | 2018 Credit Facility [Member] | Line of Credit [Member] | Greater than 2.25 to 1.00, but less than or equal to 3.00 to 1.00
Debt Instrument [Line Items]
Basis spread on variable rate	1.75%
London Interbank Offered Rate (LIBOR) [Member] | 2018 Credit Facility [Member] | Line of Credit [Member] | Greater than 3.00 to 1.00
Debt Instrument [Line Items]
Basis spread on variable rate	2.00%

Retirement Plans (Detail)

Retirement Plans (Detail) - USD ($) $ in Thousands	3 Months Ended			9 Months Ended
	Jul. 31, 2021	Jul. 31, 2020	Oct. 31, 2019	Jul. 31, 2021	Jul. 31, 2020	Oct. 31, 2020
Retirement Benefits [Abstract]
Defined benefit plan, contributions by employer			$ 3,700	$ 500
Supplemental benefit plan liability	$ 2,800			2,800		$ 2,600
Deferred compensation liability	3,600			3,600		$ 3,300
Net periodic benefit cost:
Service cost	212	$ 242		637	$ 1,022
Interest cost	189	280		567	853
Expected return on plan assets	(490)	(509)		(1,470)	(1,503)
Amortization of net loss	36	(4)		108	200
Net periodic pension (benefit) cost	$ (53)	$ 9		$ (158)	$ 572

Income Taxes (Detail)

Income Taxes (Detail) - USD ($) $ in Millions	9 Months Ended
	Jul. 31, 2021	Jul. 31, 2020	Oct. 31, 2020
Income Tax Disclosure [Abstract]
Effective Income Tax Rate Reconciliation, Percent	32.50%	29.70%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent	21.00%
Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount	$ 3.1
Effective Income Tax Rate Reconciliation, Vesting or Exercise Of Share-based Payment Arrangement, Amount	0.6	$ 0.5
Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount	0.6
Liability for uncertain tax positions	0.5
Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued	0.2
Valuation allowance	$ 1.5		$ 1.5
Income Tax Disclosure
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent	21.00%
Minimum | Her Majesty's Revenue and Customs (HMRC)
Income Tax Disclosure [Abstract]
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent	19.00%
Income Tax Disclosure
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent	19.00%
Maximum | Her Majesty's Revenue and Customs (HMRC)
Income Tax Disclosure [Abstract]
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent	25.00%
Income Tax Disclosure
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent	25.00%

Stock Based Compensation (Detai

Stock Based Compensation (Details)	Jul. 31, 2021shares
Share-based Payment Arrangement [Abstract]
Number of shares authorized, originally	3,139,895

Stock-Based Compensation - Rest

Stock-Based Compensation - Restricted Stock Awards (Details) - Restricted Stock Awards (RSAs) - USD ($)	9 Months Ended
	Jul. 31, 2021	Jul. 31, 2020	Oct. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period	3 years
Number of Shares
Nonvested (in shares)	216,400		187,500
Grants (in shares)	73,300
Cancelled (in shares)	0
Vested (in shares)	(44,400)
Weighted Average Grant Date Fair Value per Share
Non-vested at beginning of the period (in usd per share)	$ 16.82
Granted (in usd per share)	20.68
Cancelled (in usd per share)	0
Vested (in usd per share)	20.70
Non-vested at end of the period (in usd per share)	$ 17.28
Fair value of restricted stock awards vested	$ 900,000	$ 1,100,000
Unrecognized compensation cost - non vested restricted stock awards	$ 1,800,000
Weighted-average period over which unrecognized cost is expected to be recognized	1 year 10 months 24 days

Stock-Based Compensation - Stoc

Stock-Based Compensation - Stock Options (Details) - USD ($) $ / shares in Units, $ in Thousands	9 Months Ended
	Jul. 31, 2021	Jul. 31, 2020
Stock Options, [Roll Forward]
Outstanding at beginning of period (in shares)	1,095,329
Granted (in shares)	0
Exercised (in shares)	(865,393)
Forfeited/Expired (in shares)	(2,500)
Outstanding at end of period (in shares)	227,436
Vested (in shares)	227,436
Exercisable at end of period (in shares)	227,436
Weighted Average Exercise Price
Outstanding at beginning of period (in usd per share)	$ 18.88
Granted (in usd per share)	0
Exercised (in usd per share)	18.80
Forfeited/Expired (in usd per share)	18.22
Outstanding at end of period (in usd per share)	19.20
Vested or expected to vest at end of period (in usd per share)	19.20
Exercisable at end of period (in usd per share)	$ 19.20
Weighted Average Remaining Contractual Life
Outstanding, weighted average remaining contractual life	3 years 6 months
Vested, remaining contractual life	3 years 6 months
Exercisable, weighted average remaining contractual life	3 years 6 months
Aggregate Intrinsic Value
Outstanding at end of period	$ 1,283
Vested or expected to vest at end of period	1,283
Exercisable at end of period	$ 1,283
Stock Options
Stock Options, [Roll Forward]
Exercised (in shares)	(865,393)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period	3 years
Total intrinsic value of options exercised	$ 4,200	$ 500
Fair value of stock options vested		$ 400

Stock-Based Compensation - Re_2

Stock-Based Compensation - Restricted Stock Units (Details) - USD ($) $ / shares in Units, $ in Thousands	9 Months Ended
	Jul. 31, 2021	Jul. 31, 2020
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period	3 years
Grants (in shares)	28,826	25,326
Granted (in usd per share)	$ 18.79	$ 19.02
Nonvested (in shares)	21,774
Vested (in usd per share)	$ 17.08
Cash paid to settle vested units	$ 800
Performance Shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grants (in shares)	32,322

Stock-Based Compensation - Perf

Stock-Based Compensation - Performance Share Awards (Details) - Performance Shares - USD ($) $ / shares in Units, $ in Millions	Dec. 02, 2020	Dec. 05, 2019	Dec. 05, 2018	Jul. 31, 2021	Jul. 31, 2020	Jul. 31, 2021	Jul. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance shares settled in cash						100.00%
Performance shares granted	65,300	55,900	132,400
Return On Net Assets	$ 20.68	$ 19.40	$ 13.63
Performance shares forfeited	0	5,300	40,900
Performance shares compensation expense				$ 0.7	$ 0.1	$ 4	$ (0.3)
Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance shares vesting percentage maximum						0.00%
Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance shares vesting percentage maximum						200.00%

Stock-Based Compensation - Pe_2

Stock-Based Compensation - Performance Restricted Stock Units (Details) - Performance Restricted Stock Units - USD ($) $ / shares in Units, $ in Millions	Dec. 02, 2020	Dec. 05, 2019	Dec. 05, 2018	Jul. 31, 2021	Jul. 31, 2020	Jul. 31, 2021	Jul. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period						3 years
Performance restricted stock units settled in cash						100.00%
Performance Restricted Stock Units Granted	38,400	35,000	89,200
Granted (in usd per share)	$ 20.68	$ 19.40	$ 13.63
Performance restricted stock units shares forfeited	0	0	25,500
Vested (in shares)						32,322
Share-based Payment Arrangement, Expense				$ 0.1	$ 0.1	$ 0.5	$ 0.4
Performance restricted stock units as probable to vest				92,104		92,104
Level 1 [Member] | A-TSR greater than or equal to 50% [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance restricted stock units vesting percentage maximum						150.00%
Level 2 [Member] | A-TSR less than 50% and greater than or equal to 20% [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance restricted stock units vesting percentage maximum						100.00%
Level 3 [Member] | A-TSR less than 20% and greater than or equal to -20% [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance restricted stock units vesting percentage maximum						50.00%
Level 4 [Member] | A-TSR less than -20% [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance restricted stock units vesting percentage maximum						0.00%
Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance restricted stock units vesting percentage maximum						0.00%
Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance restricted stock units vesting percentage maximum						150.00%

Stock-Based Compensation - Trea

Stock-Based Compensation - Treasury Shares (Details) - shares	9 Months Ended
	Jul. 31, 2021	Oct. 31, 2020
Treasury Stock [Abstract]
Beginning Balance as of November 1, 2020	3,751,722	4,491,429
Stock options exercised	(865,393)
Treasury stock repurchases	231,308
Balance at July 31, 2021	3,751,722
Restricted Stock Awards (RSAs)
Treasury Stock [Abstract]
Restricted stock awards granted	(73,300)
Performance Shares
Treasury Stock [Abstract]
Restricted stock awards granted	(32,322)
Stock Options
Treasury Stock [Abstract]
Stock options exercised	(865,393)

Other, net (Details)

Other, net (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 31, 2021	Jul. 31, 2020	Jul. 31, 2021	Jul. 31, 2020
Other Income and Expenses [Abstract]
Foreign currency transaction losses	$ (79)	$ (458)	$ (161)	$ (375)
Foreign currency derivative losses	0	0	0	(15)
Pension service benefit	265	232	795	449
Interest income	0	5	4	24
Other	2	1	7	33
Other, net	$ 188	$ (220)	$ 645	$ 116

Segment Information (Details)

Segment Information (Details) $ in Millions	3 Months Ended		9 Months Ended
	Jul. 31, 2021USD ($)	Jul. 31, 2020USD ($)	Jul. 31, 2021USD ($)segment	Jul. 31, 2020USD ($)
Segment Reporting Information [Line Items]
Number of reportable segments			3
Allocated corporate general and administrative expense | $	$ 4.9	$ 5.2	$ 15.6	$ 15.4
Operating Segments | NA Fenestration
Segment Reporting Information [Line Items]
Number of operating segments			3

Segment Information Segment Rep

Segment Information Segment Reporting Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 31, 2021	Jul. 31, 2020	Jul. 31, 2021	Jul. 31, 2020	Oct. 31, 2020
Segment Reporting Information [Line Items]
Net sales	$ 279,877	$ 212,096	$ 780,381	$ 596,168
Depreciation and amortization	10,683	11,060	32,543	35,851
Operating income (loss)	21,562	16,563	54,777	27,436
Capital expenditures	6,207	4,360	16,006	20,673
Total assets	719,192		719,192		$ 691,585
Operating Segments | NA Fenestration
Segment Reporting Information [Line Items]
Net sales	147,818	122,386	422,077	341,432
Depreciation and amortization	4,571	5,371	14,528	18,311
Operating income (loss)	13,302	12,383	40,288	21,442
Capital expenditures	2,651	1,963	7,472	13,199
Total assets	264,286		264,286		252,703
Operating Segments | EU Fenestration
Segment Reporting Information [Line Items]
Net sales	71,114	38,265	181,862	104,230
Depreciation and amortization	2,646	2,307	7,771	7,045
Operating income (loss)	11,464	5,365	29,901	9,140
Capital expenditures	2,285	1,787	4,025	3,413
Total assets	244,381		244,381		223,248
Operating Segments | NA Cabinet Components
Segment Reporting Information [Line Items]
Net sales	61,936	51,925	179,492	152,634
Depreciation and amortization	3,390	3,264	9,965	10,139
Operating income (loss)	(918)	(193)	(1,215)	(3,481)
Capital expenditures	1,115	602	4,228	3,946
Total assets	176,625		176,625		174,713
Corporate Non-Segment
Segment Reporting Information [Line Items]
Net sales	(991)	(480)	(3,050)	(2,128)
Depreciation and amortization	76	118	279	356
Operating income (loss)	(2,286)	(992)	(14,197)	335
Capital expenditures	156	$ 8	281	$ 115
Total assets	$ 33,900		$ 33,900		$ 40,921

Segment Information Goodwill by

Segment Information Goodwill by Segment (Details) $ in Thousands	9 Months Ended
	Jul. 31, 2021USD ($)
Goodwill [Line Items]
Beginning balance	$ 146,154
Foreign currency translation adjustment	4,333
Balance as of the end of the period	150,487
Operating Segments | NA Fenestration
Goodwill [Line Items]
Beginning balance	38,712
Foreign currency translation adjustment	0
Balance as of the end of the period	38,712
Operating Segments | EU Fenestration
Goodwill [Line Items]
Beginning balance	68,295
Foreign currency translation adjustment	4,333
Balance as of the end of the period	72,628
Operating Segments | NA Cabinet Components
Goodwill [Line Items]
Beginning balance	39,147
Foreign currency translation adjustment	0
Balance as of the end of the period	39,147
Corporate Non-Segment
Goodwill [Line Items]
Beginning balance	0
Foreign currency translation adjustment	0
Balance as of the end of the period	$ 0

Segment Information Reconcillia

Segment Information Reconcilliation of Operating Loss to Net Income (Details) - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Jul. 31, 2021	Apr. 30, 2021	Jan. 31, 2021	Jul. 31, 2020	Apr. 30, 2020	Jan. 31, 2020	Jul. 31, 2021	Jul. 31, 2020
Segment Reporting [Abstract]
Operating income	$ 21,562			$ 16,563			$ 54,777	$ 27,436
Interest expense	(597)			(1,165)			(1,988)	(4,310)
Other, net	188			(220)			645	116
Income tax expense	(7,474)			(4,345)			(17,352)	(6,898)
Net income	$ 13,679	$ 14,551	$ 7,852	$ 10,833	$ 5,501	$ 10	$ 36,082	$ 16,344

Earnings Per Share (Details)

Earnings Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 31, 2021	Jul. 31, 2020	Jul. 31, 2021	Jul. 31, 2020
Earnings Per Share Disclosure [Line Items]
Basic earnings per common share	$ 13,679	$ 10,833	$ 36,082	$ 16,344
Diluted earnings per common share	$ 13,679	$ 10,833	$ 36,082	$ 16,344
Basic (in shares)	33,359,000	32,610,000	33,194,000	32,716,000
Diluted (in shares)	33,650,000	32,739,000	33,518,000	32,845,000
Basic earnings per common share	$ 0.41	$ 0.33	$ 1.09	$ 0.50
Diluted earnings per common share	$ 0.41	$ 0.33	$ 1.08	$ 0.50
Antidilutive securities (in shares)	0	1,190,000	0	1,158,000
Stock Options
Earnings Per Share Disclosure [Line Items]
Weighted Average Number Diluted Shares Outstanding Adjustment	59,000	1,000	103,000	5,000
Antidilutive securities (in shares)	0	1,139,000	0	1,107,000
Restricted Stock Awards (RSAs)
Earnings Per Share Disclosure [Line Items]
Weighted Average Number Diluted Shares Outstanding Adjustment	140,000	86,000	129,000	82,000
Antidilutive securities (in shares)	0	51,000	0	51,000
Performance Shares
Earnings Per Share Disclosure [Line Items]
Weighted Average Number Diluted Shares Outstanding Adjustment		17,000		17,000
Performance Restricted Stock Units
Earnings Per Share Disclosure [Line Items]
Weighted Average Number Diluted Shares Outstanding Adjustment	92,000	25,000	92,000	25,000